These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3839678

  • 1. Ultrastructural development of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium.
    Boyce RW, Weisbrode SE, Kindig O.
    Bone; 1985; 6(3):165-72. PubMed ID: 3839678
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
    Boyce RW, Weisbrode SE.
    Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
    [Abstract] [Full Text] [Related]

  • 5. Light- and electron-microscopic evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats.
    Weisbrode SE, Capen CC, Norman AW.
    Am J Pathol; 1979 Nov; 97(2):247-60. PubMed ID: 525673
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fine structural changes of bone cells in experimental nutritional osteodystrophy of green iguanas.
    Anderson MP, Capen CC.
    Virchows Arch B Cell Pathol; 1976 Apr 29; 20(3):169-84. PubMed ID: 818799
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG.
    Calcif Tissue Int; 1986 Apr 29; 38(4):234-8. PubMed ID: 3085902
    [Abstract] [Full Text] [Related]

  • 11. Ultrastructural immunocytochemical localization of endogenous 1,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria.
    Boivin G, Mesguich P, Pike JW, Bouillon R, Meunier PJ, Haussler MR, Dubois PM, Morel G.
    Bone Miner; 1987 Nov 29; 3(2):125-36. PubMed ID: 2850050
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ, Hott M, Garba MT.
    Calcif Tissue Int; 1985 May 29; 37(3):268-75. PubMed ID: 3926276
    [Abstract] [Full Text] [Related]

  • 14. Effects of parathyroid hormone on bone of thyroparathyroidectomized rats: an ultrastructural and enzymatic study.
    Weisbrode SE, Capen CC, Nagode LA.
    Am J Pathol; 1974 Jun 29; 75(3):529-41. PubMed ID: 4275712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats.
    Vukicević S, Krempien B, Stavljenić A.
    J Bone Miner Res; 1987 Dec 29; 2(6):533-45. PubMed ID: 3502683
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
    Finch JL, Brown AJ, Mori T, Nishii Y, Slatopolsky E.
    J Bone Miner Res; 1992 Jul 29; 7(7):835-9. PubMed ID: 1642151
    [Abstract] [Full Text] [Related]

  • 20. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats.
    Verhaeghe J, Suiker AM, Van Bree R, Van Herck E, Jans I, Visser WJ, Thomasset M, Allewaert K, Bouillon R.
    Am J Physiol; 1993 Aug 29; 265(2 Pt 1):E215-23. PubMed ID: 8368291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.